http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Matsumoto, Kazumasa,Mochizuki, Kohei,Hirayama, Takahiro,Ikeda, Masaomi,Nishi, Morihiro,Tabata, Ken-ichi,Okazaki, Miyoko,Fujita, Tetsuo,Taoka, Yoshinori,Iwamura, Masatsugu Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.6
This study was conducted to evaluate the effectiveness of a combination of gemcitabine and nedaplatin therapy among patients with metastatic urothelial carcinoma previously treated with two lines of chemotherapy. Between February 2009 and August 2013, 30 patients were treated with gemcitabine and paclitaxel as a second-line chemotherapy. All had received a first-line chemotherapy consisting of methotrexate, vinblastine, doxorubicin and cisplatin. Ten patients who had measurable histologically proven advanced or metastatic urothelial carcinoma of the urinary bladder and upper urinary tract received gemcitabine $1,000mg/m^2$ on days 1, 8 and 15 and nedaplatin $70mg/m^2$ on day 2 as a third-line chemotherapy. Tumors were assessed by imaging every two cycles. The median number of treatment cycles was 3.5. One patient had partial response and three had stable disease. The disease-control rate was 40%, the median overall survival was 8.8 months and the median progression-free survival was 5.0 months. The median overall survival times for the first-line and second-line therapies were 29.1 and 13.9 months, respectively. Among disease-controlled patients (n=4), median overall survival was 14.2 months. Myelosuppression was the most common toxicity. There were no therapy-related deaths. Gemcitabine and nedaplatin chemotherapy is a favorable third-line chemotherapeutic option for patients with metastatic urothelial carcinoma. Given the safety and benefit profile seen in this study, further prospective trials are warranted given the implications of our results with regard to strategic chemotherapy for patients with advanced or metastatic urothelial carcinoma.
Decomposition of Category Mixture in a Pixel and its Application for Supervised Image Classification
Masao MATSUMOTO,Kohei ARAI,Takakazu ISHIMATSU 대한전자공학회 1992 대한전자공학회 학술대회 Vol.1992 No.10
To make an accurate retrieval of the proportion of each category among mixed pixels (Mixel's) of a remotely sensed imagery, a maximum likelihood estimation method of category proportion is proposed. In this method, the observed multispectral vector is considered as probability variables along with the approximation that the supervised data of each category can be characterized by normal distribution. The results show that this method can retrieve accurate proportion of each category among Mixel's. And a index that can estimate the degree of error in each category is proposed. AS one of the application of the proportion estimation, a method for image classification based on category proportion estimation is proposed. In this method all pixel in a remotely sensed imagery are assumed to be Mixel's, and are classified to most dominant category. Among the Mixel's, there exists unconfidential pixels which should be categorized as unclassified pixels. In order to discriminate them, two types of criteria, Chi square and AIC, are proposed for fitness test on pure pixel hypothesis. Experimental result with a simulated dataset show an usefulness of proposed classification criterion compared to the conventional maximum likelihood criterion and applicability of the fitness tests based on Chi square and AIC.<br/> Remote sensing;Proportion estimation;Mixel;Image Classification and Non-linear optimization
Yasuyuki Nakamura,Daisuke Hokuto,Fumikazu Koyama,Yasuko Matsuo,Takeo Nomi,Takahiro Yoshikawa,Naoki Kamitani,Tomomi Sadamitsu,Takeshi Takei,Yayoi Matsumoto,Yosuke Iwasa,Kohei Fukuoka,Shinsaku Obara,Tak 대한대장항문학회 2021 Annals of Coloproctolgy Vol.37 No.5
Purpose: Primary tumor location of colon cancer has been reported to affect the prognosis after curative resection. However, some reports suggested the impact was varied by tumor stage. This study analyzed the prognostic impact of the sidedness of colon cancer in stages II, III, and liver metastasis after curative resection using propensity-matched analysis.Methods: Right-sided colon cancer was defined as a tumor located from cecum to splenic flexure, while any more distal colon cancer was defined as left-sided colon cancer. Patients who underwent curative resection at Nara Medical University hospital between 2000 and 2016 were analyzed.Results: There were 110 patients with stage II, 100 patients with stage III, and 106 patients with liver metastasis. After propensity matching, 28 pairs with stage II and 32 pairs with stage III were identified. In the patients with stage II, overall survival (OS) and recurrence-free survival (RFS) were not significantly different for right- and left-sided colon cancers. In the patients with stage III, OS and RFS were significantly worse in right-sided colon cancer. In those with liver metastasis, OS of right-sided colon cancer was significantly worse than left-sided disease, while RFS was similar. Regarding metachronous liver metastasis, the difference was observed only in the patients whose primary colon cancer was stage III. In each stage, significantly higher rate of peritoneal recurrence was found in those with right-sided colon cancer.Conclusion: Sidedness of colon cancer had a significant and varied prognostic impact in patients with stage II, III, and liver metastasis after curative resection.